Outsourcing Outlook

Feb 02, 2017
Pharmaceutical Technology
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.
Jan 02, 2017
Pharmaceutical Technology
Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017.
Dec 07, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
M&A activity, new business models, fundraising limits, offerings from small CDMOs, and combination products are driving decisions in the contract services market.
Dec 02, 2016
Pharmaceutical Technology
Biosimilars may be the key to CMO growth.
Nov 02, 2016
Pharmaceutical Technology
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Oct 02, 2016
Pharmaceutical Technology
This key bioprocessing segment is expecting continued growth.
Sep 02, 2016
Pharmaceutical Technology
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
Aug 02, 2016
Pharmaceutical Technology
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
Jul 06, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
Bio/pharma companies that are qualifying potential contract service providers should investigate post-merger integration activities and capital structure as part of the due diligence.
Jul 02, 2016
Pharmaceutical Technology
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
native1_300x100
lorem ipsum